Taylor J. Jensen

2.4k total citations
51 papers, 1.7k citations indexed

About

Taylor J. Jensen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Taylor J. Jensen has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Taylor J. Jensen's work include Cancer Genomics and Diagnostics (18 papers), Epigenetics and DNA Methylation (11 papers) and Prenatal Screening and Diagnostics (11 papers). Taylor J. Jensen is often cited by papers focused on Cancer Genomics and Diagnostics (18 papers), Epigenetics and DNA Methylation (11 papers) and Prenatal Screening and Diagnostics (11 papers). Taylor J. Jensen collaborates with scholars based in United States, Czechia and United Kingdom. Taylor J. Jensen's co-authors include Bernard W. Futscher, Mathias Ehrich, Dirk van den Boom, Petr Novák, Cosmin Deciu, A. Jay Gandolfi, Amin R. Mazloom, Sung K. Kim, Željko Džakula and K.E. Eblin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Taylor J. Jensen

43 papers receiving 1.6k citations

Peers

Taylor J. Jensen
Aggeliki Kοlialexi Greece
Xuexi Yang China
Buran Kurdi-Haidar United States
Carmen Ili Chile
Jin Takeuchi Japan
Qizhi He China
Matthew Gormley United States
S Söderhäll Sweden
Philippe Rousselot France
Sílvia Regina Brandalise Brazil
Aggeliki Kοlialexi Greece
Taylor J. Jensen
Citations per year, relative to Taylor J. Jensen Taylor J. Jensen (= 1×) peers Aggeliki Kοlialexi

Countries citing papers authored by Taylor J. Jensen

Since Specialization
Citations

This map shows the geographic impact of Taylor J. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taylor J. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taylor J. Jensen more than expected).

Fields of papers citing papers by Taylor J. Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taylor J. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taylor J. Jensen. The network helps show where Taylor J. Jensen may publish in the future.

Co-authorship network of co-authors of Taylor J. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Taylor J. Jensen. A scholar is included among the top collaborators of Taylor J. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taylor J. Jensen. Taylor J. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishizaki, Daisuke, Sharon H. Choi, Suzanna Lee, et al.. (2025). Pan-Cancer Landscape of B- and T-Lymphocyte Attenuator: Implications for Potential Immunotherapy Combinations. JCO Precision Oncology. 9(9). e2500304–e2500304. 1 indexed citations
2.
Jackson, Jennifer, Cynthia Maddox, James R. White, et al.. (2025). Analytical Validation of the Labcorp Plasma Complete Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology. Journal of Molecular Diagnostics. 27(3). 216–231. 1 indexed citations
3.
Nishizaki, Daisuke, Hirotaka Miyashita, Suzanna Lee, et al.. (2025). B7-H3/CD276: Novel Immune Checkpoint and Jack of All Trades. ImmunoTargets and Therapy. Volume 14. 967–977.
4.
Wallen, Zachary D., Mary Nesline, Kyle C. Strickland, et al.. (2024). Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer. Frontiers in Immunology. 15. 1413956–1413956. 3 indexed citations
5.
6.
Severson, Eric A., Bhagelu R. Achyut, Mary Nesline, et al.. (2023). RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers. Journal of Molecular Diagnostics. 25(7). 454–466. 8 indexed citations
7.
Jackson, Jennifer, Eric A. Severson, Amy Greer, et al.. (2023). Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors. Journal of Molecular Diagnostics. 25(7). 477–489. 2 indexed citations
8.
9.
Jensen, Taylor J., Aaron M. Goodman, Christopher K. Ellison, et al.. (2021). Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible. Molecular Cancer Therapeutics. 20(11). 2274–2279. 7 indexed citations
10.
Goodman, Aaron M., Lisa Kim, Kerry Fitzgerald, et al.. (2021). Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas. Transplantation and Cellular Therapy. 28(1). 30.e1–30.e7. 18 indexed citations
11.
Jensen, Taylor J., Aaron M. Goodman, Shumei Kato, et al.. (2018). Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients. Molecular Cancer Therapeutics. 18(2). 448–458. 67 indexed citations
12.
Ikeda, Sadakatsu, Aaron M. Goodman, Philip R. Cohen, et al.. (2016). Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy. npj Genomic Medicine. 1(1). 94 indexed citations
13.
Jensen, Taylor J., Sung K. Kim, Zhanyang Zhu, et al.. (2015). Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains. Genome Biology. 16(1). 78–78. 54 indexed citations
14.
Teoh-Fitzgerald, Melissa, Matthew P. Fitzgerald, Taylor J. Jensen, Bernard W. Futscher, & Frederick E. Domann. (2011). Genetic and Epigenetic Inactivation of Extracellular Superoxide Dismutase Promotes an Invasive Phenotype in Human Lung Cancer by Disrupting ECM Homeostasis. Molecular Cancer Research. 10(1). 40–51. 67 indexed citations
15.
Jensen, Taylor J., et al.. (2011). Hypomethylation of the 14‐3‐3σ promoter leads to increased expression in non‐small cell lung cancer. Genes Chromosomes and Cancer. 50(10). 830–836. 22 indexed citations
16.
Novák, Petr, Taylor J. Jensen, James C. Garbe, Martha R. Stampfer, & Bernard W. Futscher. (2009). Stepwise DNA Methylation Changes Are Linked to Escape from Defined Proliferation Barriers and Mammary Epithelial Cell Immortalization. Cancer Research. 69(12). 5251–5258. 94 indexed citations
17.
Jensen, Taylor J., et al.. (2009). Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells. Toxicology and Applied Pharmacology. 241(2). 221–229. 32 indexed citations
18.
Novák, Petr, Taylor J. Jensen, Marc M. Oshiro, et al.. (2008). Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast Cancer. Cancer Research. 68(20). 8616–8625. 122 indexed citations
19.
Jensen, Taylor J., et al.. (2008). Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicology and Applied Pharmacology. 235(1). 39–46. 71 indexed citations
20.
Novák, Petr, Taylor J. Jensen, Marc M. Oshiro, et al.. (2006). Epigenetic Inactivation of the HOXA Gene Cluster in Breast Cancer. Cancer Research. 66(22). 10664–10670. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aggeliki Kοlialexi Breakdown of academic impact, for papers by Xuexi Yang Breakdown of academic impact, for papers by Buran Kurdi-Haidar Breakdown of academic impact, for papers by Carmen Ili Breakdown of academic impact, for papers by Jin Takeuchi Breakdown of academic impact, for papers by Qizhi He Breakdown of academic impact, for papers by Matthew Gormley Breakdown of academic impact, for papers by S Söderhäll Breakdown of academic impact, for papers by Philippe Rousselot Breakdown of academic impact, for papers by Sílvia Regina Brandalise
Rankless by CCL
2026